Sulfathiazole)
Generic Name: sulfathiazole)
Manufactured by FOUGERA. Dosage form: TABLET. Route: VAGINAL. Active ingredients: TRIPLE SULFA (SULFABENZAMIDE (184MG); SULFACETAMIDE (143.75MG); SULFATHIAZOLE) (172.5MG). Application: ANDA088463.
Overview
Manufactured by FOUGERA. Dosage form: TABLET. Route: VAGINAL. Active ingredients: TRIPLE SULFA (SULFABENZAMIDE (184MG); SULFACETAMIDE (143.75MG); SULFATHIAZOLE) (172.5MG). Application: ANDA088463.
Dosage
Available as tablet for vaginal use.
Related Medications
Mens Massage Cream
mens massage cream
Non-Standardized Chemical Allergen [EPC]
Skin absorbs it easily, leaving skinhydrated, smooth, Deep moisturizing and nourishing skin, nongreasy, no sticky residue
Pazopanib
pazopanib
11 DESCRIPTION Pazopanib is a kinase inhibitor. Pazopanib is presented as the hydrochloride salt, with the chemical name 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide hydrochloride. It has the molecular formula C 21 H 23 N 7 O 2 S•HCl and a molecular weight of 473.99 g/mol. Pazopanib hydrochloride has the following chemical structure: Pazopanib hydrochloride is a white to slightly yellow solid.
Ulipristal Acetate
ulipristal acetate
11 DESCRIPTION The ella (ulipristal acetate) tablet for oral use contains 30 mg of a single active steroid ingredient, ulipristal acetate [17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione], a synthetic progesterone agonist/antagonist. The inactive ingredients are lactose monohydrate, povidone K-30, croscarmellose sodium and magnesium stearate. Ulipristal acetate is a white to yellow crystalline powder which has a molecular weight of 475.6.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.